AAAAAA

   
Results: 1-2 |
Results: 2
SB 239063, a second-generation p38 mitogen-activated protein kinase inhibitor, reduces brain injury and neurological deficits in cerebral focal ischemia
Authors: Barone, FC Irving, EA May, AM Lee, JC Kassis, S Kumar, S Badger, AM White, RF McVey, MJ Legos, JJ Erhardt, JA Nelson, AH Ohlstein, EH Hunter, AJ Ward, K Smith, BR Adams, JL Parsons, AA
Citation: Fc. Barone et al., SB 239063, a second-generation p38 mitogen-activated protein kinase inhibitor, reduces brain injury and neurological deficits in cerebral focal ischemia, J PHARM EXP, 296(2), 2001, pp. 312-321
Cardiovascular pharmacology of the adenosine A(1)/A(2)-receptor agonist AMP 579: Coronary hemodynamic and cardioprotective effects in the canine myocardium
Authors: McVey, MJ Smits, GJ Cox, BF Kitzen, JM Clark, KL Perrone, MH
Citation: Mj. Mcvey et al., Cardiovascular pharmacology of the adenosine A(1)/A(2)-receptor agonist AMP 579: Coronary hemodynamic and cardioprotective effects in the canine myocardium, J CARDIO PH, 33(5), 1999, pp. 703-710
Risultati: 1-2 |